1031 related articles for article (PubMed ID: 6595558)
1. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
Levy L; Woodfield DG
N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
[TBL] [Abstract][Full Text] [Related]
2. Donor selection in platelet transfusion therapy of alloimmunized thrombocytopenic patients.
Duqesnoy RJ
Prog Clin Biol Res; 1978; 28():229-43. PubMed ID: 88057
[No Abstract] [Full Text] [Related]
3. [Experience of HLA-matched platelet transfusion in patients who are refractory to random donor platelets].
Sekiguchi S; Mitani T; Ohnuma M; Katoh T; Ikeda H; Nakase T; Morioka M; Sakurada K; Miyazaki T
Hokkaido Igaku Zasshi; 1988 Jul; 63(4):552-61. PubMed ID: 3220437
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of antibody response to human platelet transfusion.
Wu KK; Thompson JS; Koepke JA; Hoak JC; Flink R
J Clin Invest; 1976 Aug; 58(2):432-8. PubMed ID: 956376
[TBL] [Abstract][Full Text] [Related]
5. Platelet crossmatch testing for donor selection.
Slichter SJ
Prog Clin Biol Res; 1982; 88():153-64. PubMed ID: 7100207
[TBL] [Abstract][Full Text] [Related]
6. Transfusion strategy: use of HLA-matched platelet transfusions for alloimmunized patients.
Menitove JE; Duquesnoy RJ
Am J Med Technol; 1981 Feb; 47(2):114-20. PubMed ID: 7223758
[TBL] [Abstract][Full Text] [Related]
7. [Transfusion of platelet concentrates].
Rieux C; Lee K; Lavaud A; Bierling P
Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
[TBL] [Abstract][Full Text] [Related]
8. [Thrombocyte replacement in hematologic diseases].
Höcker P
Wien Klin Wochenschr; 1985 Nov; 97(22):841-7. PubMed ID: 3909651
[TBL] [Abstract][Full Text] [Related]
9. Role of HLA-C matching in histocompatible platelet transfusion therapy of alloimmunized thrombocytopenic patients.
Duquesnoy RJ; Filip DJ; Tomasulo PA; Aster RH
Transplant Proc; 1977 Dec; 9(4):1827-8. PubMed ID: 601843
[No Abstract] [Full Text] [Related]
10. In vivo efficacy of shipped HLA-matched platelets.
Haddad SA; Lichtiger B; Klein HG
Transfusion; 2006 Aug; 46(8):1306-10. PubMed ID: 16934064
[TBL] [Abstract][Full Text] [Related]
11. Variable expression of w4 and w6 on platelets: possible relevance to platelet transfusion therapy of alloimmunized thrombocytopenic patients.
Duquesnoy RJ; Testin J; Aster RH
Transplant Proc; 1977 Dec; 9(4):1829-31. PubMed ID: 601844
[No Abstract] [Full Text] [Related]
12. The platelet-refractory bone marrow transplant patient: prophylaxis and treatment of bleeding.
Benson K; Fields K; Hiemenz J; Zorsky P; Ballester O; Perkins J; Elfenbein G
Semin Oncol; 1993 Oct; 20(5 Suppl 6):102-9. PubMed ID: 8211211
[TBL] [Abstract][Full Text] [Related]
13. [Substitution ofpolysensitized patients with platelets from HL-A typed single donors].
Gmür J; Baumberger U; von Felten A
Schweiz Med Wochenschr; 1976 Oct; 106(40):1358-9. PubMed ID: 1006253
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of HLA-alloimmunization of recipients of platelet concentrates].
Kuntz BM; Wollenhaupt HJ; Brüster HT
Beitr Infusionsther; 1991; 28():209-12. PubMed ID: 1725621
[TBL] [Abstract][Full Text] [Related]
15. Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients.
Duquesnoy RJ; Filip DJ; Rodey GE; Rimm AA; Aster RH
Am J Hematol; 1977; 2(3):219-26. PubMed ID: 596366
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of leukocyte-depleted platelet concentrates for prevention of HLA-alloimmunization in patients with frequent platelet transfusions: a prospective multi-institutional study using a polyester platelet filter].
Handa M; Ikeda Y; Kurata Y; Tsubaki K; Horiuchi A; Furihata K; Kimura Y; Toyama K; Takamoto S; Tsukimoto I
Rinsho Ketsueki; 1992 Apr; 33(4):451-60. PubMed ID: 1602608
[TBL] [Abstract][Full Text] [Related]
17. [The effect of HLA alloimmunization and other factors on the effectiveness of thrombocyte concentrates].
Pittrová H; Koza V; Cepelák V; Bufková D
Cas Lek Cesk; 1990 Jun; 129(24):751-3. PubMed ID: 2393882
[TBL] [Abstract][Full Text] [Related]
18. Establishment of platelet donor registry improves the treatment of platelet transfusion refractoriness in Guangzhou region of China.
Xia WJ; Ye X; Tian LW; Xu XZ; Chen YK; Luo GP; Bei CH; Deng J; Santoso S; Fu YS
Transfus Med; 2010 Aug; 20(4):269-74. PubMed ID: 20136782
[TBL] [Abstract][Full Text] [Related]
19. [Thrombocyte transfusion: increase in platelets in relation to clinical and immunologic prerequisites].
Panzer S; Maier F; Höcker P; Mayr WR; Hinterberger W
Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():10-4. PubMed ID: 3298059
[TBL] [Abstract][Full Text] [Related]
20. Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer.
Pedrazzoli P; Perotti C; Noris P; Da Prada GA; Zibera C; Battaglia M; Gibelli N; Preti P; Pavesi L; Torretta L; Balduini CL; Salvaneschi L; Robustelli della Cuna G
Haematologica; 1998 Aug; 83(8):718-23. PubMed ID: 9793256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
